Product Development Through Co-Creation with Customers
First written in FY2017-Q1. 16 of 17 entries say "Restated". Latest entry: FY2023-Q2.
11 other companies' latest entry also says "Restated".
- FY2023-Q2RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current second quarter of the cumulative consolidated period was ¥764 million. There were no material changes in the group’s R&D activities during the current second quarter of the cumulative consolidated period.」
The Group disclosed that there had been no material changes in its R&D activities, including co-creation with customers and business partners, and disclosed R&D expenditure of ¥764 million for the second quarter cumulative period. - FY2023-Q1RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current first quarter of the cumulative consolidated period was ¥396 million. There were no material changes in the group’s R&D activities during the current first quarter of the cumulative consolidated period.」
The Group disclosed that there had been no material changes in its R&D activities, including co-creation with customers and business partners, and disclosed R&D expenditure of ¥396 million for the first quarter cumulative period. - FY2022-Q2RestatedAnnual report
「R&D expenditure for the entire Group during the second quarter of the current consolidated cumulative period was ¥735 million.」
The entire Group continues its R&D activities and disclosed R&D expenditure of ¥735 million for the second quarter cumulative period. - FY2021-Q3RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current third quarter of the cumulative consolidated period was ¥1,123 million. There were no material changes in the group’s R&D activities during the current third quarter of the cumulative consolidated period.」
The entire Group continues its R&D activities and disclosed R&D expenditure of ¥1,123 million for the third quarter cumulative period. - FY2021-Q2RestatedAnnual report
「The amount spent on R&D activities by the group as a whole during the current second quarter of the cumulative consolidated period was ¥734 million. There were no material changes in the group’s R&D activities during the current second quarter of the cumulative consolidated period.」
The Group continues its R&D activities and disclosed R&D expenditure of ¥734 million for the second quarter cumulative period. - FY2020-Q2RestatedAnnual report
「R&D expenditure for the entire Group during the second quarter of the current consolidated cumulative period was ¥821 million. There were no material changes in the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
The Group continues its R&D activities and disclosed R&D expenditure of ¥821 million for the second quarter cumulative period. It stated that there had been no material changes in its R&D activities. - FY2020-Q1RestatedAnnual report
「R&D expenditure for the entire Group during the first quarter of the current consolidated cumulative period was ¥406 million. There were no material changes in the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
The Group continues its R&D activities and disclosed R&D expenditure of ¥406 million for the first quarter cumulative period. It stated that there had been no material changes in its R&D activities. - FY2019RestatedAnnual report
「In product development, the product development divisions of each Group company, under the Group R&D head, are actively developing and renewing products to provide valuable products to customers and business partners, in order to put into practice the Group philosophy, “We contribute to the realization of a healthy and prosperous society through our businesses.” Total R&D expenditure for the current consolidated fiscal year was ¥1,822 million.」
The Group continues to provide valuable products to customers and business partners and develop and renew products, and disclosed annual R&D expenditure of ¥1,822 million. - FY2019-Q3RestatedAnnual report
「R&D expenditure for the entire Group during the third quarter of the current consolidated cumulative period was ¥1,458 million. From the first quarter of the current consolidated cumulative period, the Group appointed an executive officer responsible for the R&D domain at the Company in order to leverage its technologies and product development expertise across the Group, and placed a Group R&D head under that officer to address issues with greater speed.」
The Group continues its R&D activities and disclosed R&D expenditure of ¥1,458 million for the third quarter cumulative period. It also reiterated the organizational structure consisting of the executive officer responsible for R&D and the Group R&D head. - FY2019-Q2RestatedAnnual report
「R&D expenditure for the entire Group during the second quarter of the current consolidated cumulative period was ¥928 million.」
The Group continues its R&D activities, including co-creation with customers and business partners, and disclosed R&D expenditure of ¥928 million for the second quarter cumulative period. - FY2018RestatedAnnual report
「In product development, the Group is implementing the provision of valuable products to customers and business partners through co-creation and actively working to improve profitability through Group synergies. Total R&D expenditure for the current consolidated fiscal year was ¥1,791 million.」
The Group continues product development through co-creation with customers and business partners, along with its R&D activities, and disclosed annual R&D expenditure of ¥1,791 million. - FY2018-Q3RestatedAnnual report
「R&D expenditure for the entire Group during the third quarter of the current consolidated cumulative period was ¥1,345 million. There were no material changes in the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
The Group disclosed R&D expenditure of ¥1,345 million for the third quarter cumulative period and stated that there had been no material changes in its R&D activities. - FY2018-Q1RestatedAnnual report
「R&D expenditure for the entire Group during the first quarter of the current consolidated cumulative period was ¥423 million.」
The Group continues its R&D activities and disclosed R&D expenditure of ¥423 million for the first quarter cumulative period. It also stated that there had been no material changes in its R&D activities. - FY2017RestatedAnnual report
「Total R&D expenditure for the current consolidated fiscal year was ¥1,797 million.」
The Group continues co-creation with customers and business partners through the Creation Lab, along with its R&D activities, and disclosed annual R&D expenditure of ¥1,797 million. - FY2017-Q3RestatedAnnual report
「R&D expenditure for the entire Group during the third quarter of the current consolidated cumulative period was ¥1,146 million.」
The Group disclosed R&D expenditure of ¥1,146 million and continues co-creation by its Central Research Institute, product development divisions, R&D units and Creation Lab. - FY2017-Q2RestatedAnnual report
「R&D expenditure for the entire Group during the second quarter of the current consolidated cumulative period was ¥757 million.」
The Group continues to disclose R&D expenditure and pursue co-creation with customers and business partners through the Creation Lab, as well as Group synergies. - FY2017-Q1First statedAnnual report
「R&D expenditure for the entire Group during the first quarter of the current consolidated cumulative period was ¥381 million.」
The 伊藤ハム Creation Lab, opened in April 2015, entered its second year and is putting into practice the provision of valuable products through co-creation with customers and business partners.